These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36214140)

  • 1. OCT-A in chronic central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: A comparative study.
    Clemente L; Cennamo G; Montorio D; Fossataro F; Passaro ML; Costagliola C
    Eur J Ophthalmol; 2022 Oct; ():11206721221131129. PubMed ID: 36214140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of vessel density by optical coherence tomography angiography in patients with central serous chorioretinopathy after low-fluence photodynamic therapy.
    Cennamo G; Montorio D; Comune C; Clemente L; Iovino C; Carandente R; Tranfa F
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101742. PubMed ID: 32198017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.
    Rabiolo A; Zucchiatti I; Marchese A; Baldin G; Sacconi R; Montorio D; Cicinelli MV; Querques L; Bandello F; Querques G;
    Eye (Lond); 2018 Jan; 32(1):55-66. PubMed ID: 29265111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Coherence Tomography Angiography Parameters in Indian Patients With Central Serous Chorioretinopathy.
    Sodhi PK; Rao KC; R AT; Gautam A; D D; Rana AS; Kumar R; Santra S; Mohapatra A
    Cureus; 2023 Oct; 15(10):e46467. PubMed ID: 37927676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Retinochoroidal Vascular and Structural Changes after Half-Dose Photodynamic Therapy versus Half-Fluence Photodynamic Therapy Based on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.
    Karasu B; Akbas YB; Aykut A; Celebi ARC
    Ophthalmologica; 2022; 245(4):323-334. PubMed ID: 35249031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.
    Demircan A; Yesilkaya C; Alkin Z
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():375-378. PubMed ID: 29409857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography angiography to assess vascular remodeling of the choriocapillaris after low-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Cennamo G; Cennamo M; Caputo G; Mirra F; Pafundi PC; de Crecchio G; Cennamo G
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():162-166. PubMed ID: 31163282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Quantitative Foveal Avascular Zone and Retino-Choroidal Vessel Density Using Optical Coherence Tomography Angiography in a Healthy Indian Population.
    Sodhi PK; Shaw E; Gautam A; Yadav A; R AT; Rao KC; Sharma S; Tewari R
    Cureus; 2022 Aug; 14(8):e27669. PubMed ID: 36072178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic central serous chorioretinopathy: A comparative study.
    Manayath G; Verghese S; Ranjan R; Agrawal H; Khanna A; Narendran V; Chhablani J
    Eur J Ophthalmol; 2021 Nov; 31(6):3110-3116. PubMed ID: 33508971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.
    Hua L; Lin B; Hong J; Min HB; Han WL; Zhou TY; Zhang ZQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):278-284. PubMed ID: 29424884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK; Chang CK; Peng CH
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis.
    Aisu N; Miyake M; Hosoda Y; Mori Y; Takahashi A; Muraoka Y; Ueda-Arakawa N; Miyata M; Oishi A; Tamura H; Ooto S; Yamashiro K; Tsujikawa A
    Ophthalmol Sci; 2022 Jun; 2(2):100152. PubMed ID: 36249695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.
    Chan SY; Pan CT; Wang Q; Shi XH; Jonas JB; Wei WB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1365-1372. PubMed ID: 31037490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the choriocapillaris after photodynamic therapy for chronic central serous chorioretinopathy. A review of optical coherence tomography angiography (OCT-A) studies.
    Christou EE; Stavrakas P; Kozobolis V; Katsanos A; Georgalas I; Stefaniotou M
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1823-1835. PubMed ID: 35044503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy.
    Hayashida M; Miki A; Honda S; Nakamura M
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101955. PubMed ID: 32818640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.
    Xu Y; Su Y; Li L; Qi H; Zheng H; Chen C
    Ophthalmologica; 2017; 237(3):167-172. PubMed ID: 28171871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Demirel S; Özcan G; Yanık Ö; Batıoğlu F; Özmert E
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):905-912. PubMed ID: 30617579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Findings of OCT-angiography compared to fluorescein and indocyanine green angiography in central serous chorioretinopathy.
    Min JY; Lv Y; Yu S; Gong YY
    Lasers Surg Med; 2018 Dec; 50(10):987-993. PubMed ID: 29896889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Evaluation of Retinal Vessel Density in Central Serous Chorioretinopathy after Half-dose Photodynamic Therapy.
    Xu F; Zhou L; Lai K; Gong Y; Li L; Lian P; Huang C; Ding X; Lu L; Jin C
    Curr Eye Res; 2021 Jun; 46(6):855-864. PubMed ID: 33141608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.